Awareness of glucose-6 phosphate-dehydrogenase deficiency in celiac disease

F O Hosnut1, O Canan1, F Özcay1

  • 1Department of Pediatric Gastroenterology, Hepatology and Nutrition, Başkent University Faculty of Medicine, Ankara, TurkeyObstetric and Children Hospital, Adana, TurkeyDepartment of Pediatric Hematology, Başkent University Faculty of Medicine, Ankara, Turkey.

Insights

Individuals with celiac disease (CD) may require vitamin K for bleeding issues. However, vitamin K can cause red blood cell breakdown in those with glucose-6-phosphate dehydrogenase deficiency.

Area of Science:

  • Gastroenterology and Hematology
  • Nutritional Deficiencies

Background:

  • Celiac disease (CD) is linked to various hematological issues, including anemia and coagulopathy.
  • Vitamin K deficiency can impair blood clotting, necessitating correction before procedures like endoscopic biopsy in suspected CD patients.

Observation:

  • Vitamin K administration is crucial for correcting coagulopathy in celiac disease patients.
  • Vitamin K can induce hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Findings:

  • Coagulopathy in celiac disease patients often requires vitamin K intervention.
  • A critical interaction exists between vitamin K therapy and G6PD deficiency, posing a risk of hemolysis.

Implications:

  • Clinicians must consider G6PD deficiency when administering vitamin K to celiac disease patients.
  • Screening for G6PD deficiency is advisable in celiac disease patients requiring vitamin K therapy to prevent adverse events.
Abstract

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...